Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ChAdOx1 Chik + ChAdOx1 Zika
- Development stage
- Unknown
- Lead developer
- University of Oxford
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
ChAdOx1 Chik + ChAdOx1 Zika refers to a clinical trial program involving two separate viral vector vaccines developed by the University of Oxford. Both vaccines utilize the ChAdOx1 platform, which is based on a replication-deficient chimpanzee adenovirus. ChAdOx1 Chik is designed to express the structural polyprotein of the chikungunya virus (including Capsid, E3, E2, 6k, and E1), while ChAdOx1 Zika expresses Zika virus antigens. These biologics function as immunostimulants to induce both humoral and cellular immune responses against their respective pathogens. The program has been evaluated in Phase Ib clinical trials in Mexico to assess the safety and immunogenicity of the vaccines when administered alone or co-administered in healthy adults.
- Other names
- ChAdOx1-ChikChAdOx-1-ChikChAdOx 1-ChikChAdOx1-ZikaChAdOx-1-ZikaChAdOx 1-ZikaZIKA-University of Oxford-Chikungunya-Zika
02
Targets
CHIKV structural polyprotein (Chikungunya virus structural polyprotein)ZIKV E (Zika virus envelope protein)
Beyond the preview
Go deeper on ChAdOx1 Chik + ChAdOx1 Zika.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChAdOx1 Chik + ChAdOx1 Zika.